Literature DB >> 35446199

Linc01133 promotes proliferation and metastasis of human renal cell carcinoma through sponging miR-760.

Wei Lv1, Yan Li2, Liye Fu2, Fandong Meng2, Jun Li3.   

Abstract

Renal cell carcinoma (RCC) is one of the most frequent human tumors and has brought great threats to the health of the people around the globe. It was reported that linc01133, a long non-coding RNA (lncRNA), was involved in the pathogenesis and development of several human cancer. But the biological role of linc01133 in RCC is still not understood. The present study aimed to investigate the biological functions of linc01133 in RCC. We did some biological experiments in this study, including quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, MTT assay, wound healing assay, Transwell invasion assay and xenograft tumor assay. In this study, we found the expression levels of linc01133 markedly increased in the RCC tissues compared with the normal tissues. And we found that the over-expressing of linc01133 promoted cell proliferation, migration and invasion, the interfering of linc01133 inhibited cell proliferation, migration and invasion. Furthermore, we found that the interfering of linc01133 inhibited tumor growth in murine xenograft models. Additionally, we found that linc01133 promotes RCC cell proliferation, migration and invasion through sponging miR-760. Collectively, our work preliminarily illuminated the tumor-promoting role of linc01133 in RCC and the potential molecular mechanism. Thus, our study may provide some evidence for the treatment of RCC.

Entities:  

Keywords:  Linc01133; invasion; miR-760; proliferation; renal cell carcinoma

Mesh:

Substances:

Year:  2022        PMID: 35446199      PMCID: PMC9278430          DOI: 10.1080/15384101.2022.2054250

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  26 in total

1.  LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.

Authors:  Dong Xue; Cuixing Zhou; Hao Lu; Renfang Xu; Xianlin Xu; Xiaozhou He
Journal:  Tumour Biol       Date:  2016-10-14

2.  Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.

Authors:  Sue Ellen Touma; Jonathan S Goldberg; Paul Moench; Xiaojia Guo; Satish K Tickoo; Lorraine J Gudas; David M Nanus
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

3.  The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.

Authors:  Ji-Gen Ping; Fei Wang; Jin-Xian Pu; Ping-Fu Hou; Yan-Su Chen; Jin Bai; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2016-07-23

4.  MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.

Authors:  Chunhua Yan; Wei Zhang; Xiaodong Shi; Jiaolin Zheng; Xiaoming Jin; Jianmin Huo
Journal:  Environ Sci Pollut Res Int       Date:  2018-01-25       Impact factor: 4.223

5.  High expression of small GTPase Rab3D promotes cancer progression and metastasis.

Authors:  Jian Yang; Wei Liu; Xin'an Lu; Yan Fu; Lin Li; Yongzhang Luo
Journal:  Oncotarget       Date:  2015-05-10

Review 6.  Pancreatic metastases from renal cell carcinoma: a case report and literature review of the clinical and radiological characteristics.

Authors:  Yoshinori Hoshino; Hiroharu Shinozaki; Yuki Kimura; Yohei Masugi; Homare Ito; Toshiaki Terauchi; Masaru Kimata; Junji Furukawa; Kenji Kobayashi; Yoshiro Ogata
Journal:  World J Surg Oncol       Date:  2013-11-09       Impact factor: 2.754

7.  Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c.

Authors:  Xiaoying Zhou; Han Chen; Li Zhu; Bo Hao; Weifeng Zhang; Jie Hua; Huiyuan Gu; Wujuan Jin; Guoxin Zhang
Journal:  Oncotarget       Date:  2016-12-13

8.  MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling.

Authors:  Ling Cao; Yulin Liu; Dan Wang; Lan Huang; Feng Li; Jinbo Liu; Chaoqi Zhang; Zhibo Shen; Qun Gao; Weitang Yuan; Yi Zhang
Journal:  J Exp Clin Cancer Res       Date:  2018-04-16

9.  LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.

Authors:  Shi-Peng Li; Hai-Xu Xu; Yao Yu; Jin-Dan He; Zhen Wang; Yan-Jie Xu; Chang-Ying Wang; Hai-Ming Zhang; Rong-Xin Zhang; Jian-Jun Zhang; Zhi Yao; Zhong-Yang Shen
Journal:  Oncotarget       Date:  2016-07-05

10.  Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.

Authors:  Liyun Miao; Zhen Huang; Zhang Zengli; Hui Li; Qiufang Chen; Chenyun Yao; Hourong Cai; Yonglong Xiao; Hongping Xia; Yongsheng Wang
Journal:  Oncotarget       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.